Tracheostomy as a Management Option After Listing for Pediatric Cardiac Transplantation
Pediatric Transplantation · 2025
DOI: 10.1111/petr.70029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Elisabeth Day und 4 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Intensive Care, Freeman Hospital, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Heart Transplantation, Tracheostomy, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Children with end‐stage heart failure listed for cardiac transplantation may require mechanical ventilation and/or circulatory support whilst awaiting transplantation. A subgroup of these patients is unable to wean off mechanical ventilator support and undergo tracheostomy to enhance quality of life and allow de‐escalation of intensive care. There is limited evidence of the use of tracheostomy associated with pediatric cardiac transplantation. We describe outcomes to better inform future management of these patients.
Methods
A single‐centre, retrospective study was performed, assessing all pediatric patients (< 18 years) listed for cardiac transplant from 2006 to 2017. We assessed background demographics and outcomes, including cardiac diagnosis, complications, insertion of ventricular assist device and survival. We identified patients who underwent tracheostomy after listing and compared this group with non‐tracheostomised patients.
Results
Two hundred and eleven patients were listed for cardiac transplant, of whom 44 (21%) underwent tracheostomy after listing. The main indication for tracheostomy was failure to wean from mechanical ventilation (36%). Complications after tracheostomy included localized infection, granuloma, obstruction and hemorrhage, but were generally minor. Median time for tracheostomy decannulation was 75 days. When comparing tracheostomy versus non‐tracheostomy patients, there were no significant differences in age, weight or time to transplant. Survival was comparable between the non‐tracheostomy and tracheostomy groups at 1‐year, 97% versus 94% respectively.
Conclusion
There is no evidence from our study that patients awaiting cardiac transplant who undergo tracheostomy have significant complications or reduced survival. Tracheostomy is usually a short‐term measure and should be considered in the management of children receiving prolonged ventilation around the time of cardiac transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Paediatric Intensive Care, Freeman Hospital, Newcastle upon Tyne, UK.
- Department of Paediatric Cardiology and Cardiothoracic Surgery, Freeman Hospital, Newcastle upon Tyne, UK.
- Paediatric Ear, Nose and Throat, Great North Children's Hospital, Newcastle upon Tyne, UK.
- Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
ORCID-Profile: Elisabeth Day, Deborah Cross, David Crossland, Jason Powell, Emma Simpson
Zitieren
APA
Day, E., Cross, D., Crossland, D., Powell, J., & Simpson, E. (2025). Tracheostomy as a Management Option After Listing for Pediatric Cardiac Transplantation. Pediatric Transplantation. https://doi.org/10.1111/petr.70029
Vancouver
Day E, Cross D, Crossland D, Powell J, Simpson E. Tracheostomy as a Management Option After Listing for Pediatric Cardiac Transplantation. Pediatric Transplantation. 2025. doi:10.1111/petr.70029
BibTeX
@article{Day2025,
author = {Day, Elisabeth and Cross, Deborah and Crossland, David and Powell, Jason and Simpson, Emma},
title = {Tracheostomy as a Management Option After Listing for Pediatric Cardiac Transplantation},
journal = {Pediatric Transplantation},
year = {2025},
doi = {10.1111/petr.70029}
}
EUVIMED